Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation

Science China Life Sciences

Volumn 53, Issue 4, 2010, Pages 511-516

  Yue, Wen Tao ^a   Zhao, Xiao Ting ^a   Zhang, Li Na ^a   Liu, Zhi Dong ^a   Ma, Li ^a   Jia, Wen Yun ^a   Qian, Zhe ^a   Zhang, Chun Yan ^a   Wang, Yue ^a   Yang, Xue Hui ^a   Xu, Shao Fa ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CCNY; H1299; Lentivirus RNAi; NSCLC

Indexed keywords

CCNY PROTEIN, HUMAN; CYCLINE;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; NEOPLASM; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; HUMANS; LUNG NEOPLASMS; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN;

LENTIVIRUS;

EID: 77952298754     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-0090-8     Document Type: Article

References (11)

1. Ouyang W M, Ma Q, Li J X, et al. Cyclin D1 induction through IKB kinase B/nuclear factor-KB pathway is responsible for arseniteinduced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res, 2005, 65: 9287-9294.
2. Egloff A M, Vella L A, Finn Q J. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Res, 2006, 66: 6-10.
3. Massague J. G1 cell-cycle control and cancer. Nature, 2004, 432: 298-306.
4. Kastan M B, Bartek J. Cell-cycle checkpoints and cancer. Nature, 2004, 432: 316-323.
5. Ohtani N, Yamakoshi K, Takahashi A, et al. The p16INK4a-RB pathway: Molecular link between cellular senescence and tumor suppression. J Med Invest, 2004, 51: 146-153.
6. Jin J, Smith F D, Stark C, et al. Proteomic, functional, and domain-based analysis of in vivo binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol, 2004, 14: 1436-1450.
7. Lois C, Hong E J, Pease S, et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science, 2002, 295: 868-872.
8. Betticher D C, Heighway J, Hasleton P S, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer, 1996, 73: 294-300.
9. Yasmeen A, Berdel W E, Serve H, et al. E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn, 2003, 3: 617-633.
10. Ekberg J, Holm C, Jalili S, et al. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome. Eur J Haematol, 2005, 75: 106-115.
11. Ekberg J, Landberg G, Holm C, et al. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells. Oncogene, 2004, 23: 9082-9089.